Cellectis S.A.

CLLSNASDAQHealthcare● Active

$2.98

$-0.08(-2.61%)

Market Cap$299242994

P/E Ratio—

52W High$5.48

52W Low$1.327

Avg Volume41K

Open$2.97

Beta2.75

Net Income Financials Revenue

Cellectis S.A. (CLLS) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CLLS · net income · updated Jun 8, 2026

Core profitability metrics

CLLS · net income · margin · TTM · CAGR

Net income was −$67.6M for FY2025 (fiscal year ending 2025-12-31), down 83.9% year-over-year. Net profit margin was -92.7%. Based on available data, Cellectis S.A. has been profitable since at least 2014.

FY2025 Net Income−$67.6M▼ -83.9% YoY

Trailing 12M (TTM)−$67.3Mtrailing 4 quarters sum

Net Profit Margin-92.7%−$67.6M ÷ $72.9M

YoY Change-83.9%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2014

▸ FMP /income-statement · Annual · CLLS net income history · CLLS profit margin

Annual net income data

CLLS · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$67.6M▼ 83.9%-92.7%$72.9M

FY2024Loss−$36.8M▲ +63.6%-88.6%$41.5M

FY2023Loss−$101.1M▲ +4.8%-13385.3%$755,000

FY2022Loss−$106.1M▲ +7.1%-553.6%$19.2M

FY2021Loss−$114.2M▼ 40.9%-376.3%$30.3M

Net income vs peers (Healthcare)

CLLS vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Cellectis S.A.YOU

CLLS

−$67.6M-83.9%-92.7%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Cellectis S.A. (CLLS) reported net income of −$67.6M for FY2025 (fiscal year ending 2025-12-31), down 83.9% year-over-year. The net profit margin was -92.7% — meaning the company kept $-0.93 of every dollar of revenue as profit.

Based on available data, Cellectis S.A. has been profitable since at least 2014. Net income reached a peak of $24,320 in FY2014. Data available for 15 fiscal years.

Cellectis S.A.'s net profit margin was -92.7% for FY2025, based on the latest annual results.

Investors sometimes search for "Cellectis S.A. net worth" — the company's market capitalization is a separate figure from CLLS net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CLLS net income · 4 questions

Cellectis S.A. is not currently profitable on an annual basis. The company reported a net loss of $67.6M for FY2025.

is CLLS profitabledoes CLLS make a profitCLLS profitabilityCLLS profitable company

▸ Source: FMP /income-statement · GAAP · Cellectis S.A. · Cellectis S.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026